← Leaderboards
Edna Viegas
University Of Tx Md Anderson Can Ctr
$1,725,072
Attributed
$3,765,349
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,765,349 · 3
By mechanism
U01$2,124,467 · 1
D43$945,617 · 1
R01$695,265 · 1
Top collaborators
- Kathleen Schmeler5 shared
- Lee H. Harrison4 shared
- Jean Bisimwa Nachega4 shared
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Kathleen Schmeler$5,727,235
- Peter W Pisters$146,474
- Nicholas Navin$6,790,069
- Bing Yu$11,637,459
- Guojun Li$2,468,355
Others in their field
Other Emerging Leaders on “Resources”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Valerie Koch · University Corporation For Atmospheric Res$245,119,768
- Leonard Freedman · Leidos Biomedical Research, Inc.$230,221,950
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$128,821,882
Research focus
ResourcesProgramsMozambiqueAblationAdoptionAcquired Immunodeficiency SyndromeAdolescentAdverse EventAffectAfrica South Of The SaharaAftercareAlgorithmsAlternative TreatmentAreaAdherenceAutomated Visual EvaluationBiometryBiopsyCancer BurdenCancer EtiologyCancerousCancer RiskCapitalAcetic Acids
Grant awards (9)
A Randomized Clinical Trial to Assess the Effectiveness of Ablative Treatments for Cervical Cancer Risk Reduction in HIV+ Women living in Mozambique$459,312
U01 · FY2025 · CA
A Randomized Clinical Trial to Assess the Effectiveness of Ablative Treatments for Cervical Cancer Risk Reduction in HIV+ Women living in Mozambique$298,508
U01 · FY2025 · CA
Pitt-Mozambique Training Program(Pitt-MozHRTP) in COVID-19, Cardiovascular Disease, and Diabetes in People with HIV$58,014
D43 · FY2025 · TW
A Randomized Clinical Trial to Assess the Effectiveness of Ablative Treatments for Cervical Cancer Risk Reduction in HIV+ Women living in Mozambique$736,499
U01 · FY2024 · CA
Pitt-Mozambique Training Program(Pitt-MozHRTP) in COVID-19, Cardiovascular Disease, and Diabetes in People with HIV$291,353
D43 · FY2024 · TW
Pitt-Mozambique Training Program(Pitt-MozHRTP) in COVID-19, Cardiovascular Disease, and Diabetes in People with HIV$297,694
D43 · FY2023 · TW
A Randomized Clinical Trial to Assess the Effectiveness of Ablative Treatments for Cervical Cancer Risk Reduction in HIV+ Women living in Mozambique$630,148
U01 · FY2022 · CA
Pitt-Mozambique Training Program(Pitt-MozHRTP) in COVID-19, Cardiovascular Disease, and Diabetes in People with HIV$298,556
D43 · FY2022 · TW
A Randomized Clinical Trial to Assess the Effectiveness of Ablative Treatments for Cervical Cancer Risk Reduction in HIV+ Women living in Mozambique$695,265
R01 · FY2020 · CA